Awarded Grants

The ODC offers over 50 grant opportunities in 30+ disease areas annually to researchers across the globe, as well as within the Penn and CHOP communities. Since 2011, our grant programs have funded $17.2 million in rare disease research.

See below for a complete list of ODC-awarded grants since 2011.

Click HERE for the full list of 2020 CDKL5 Pilot Grant Programme

Awarded Grants

Displaying Results 51 - 60 of 262

Awardee Project Title Institution Grant Amount Funding Year
Edward Gilmore, MD, PhD Therapeutic screen for DNA damage in A-T patient derived motor neurons. Case Western Reserve University School of Medicine MDBR - Ataxia-Telangiectasia $87,164 2019
M. Leonor Cancela, PhD Zebrafish as model to analyze CDKL5 function University of Algarve MDBR - CDKL5 $51,382 2019
Hong Zhang, PhD Mechanistic study of WDR45/45B and their binding partner ATG2 in the autophagy pathway of neural cells University of Massachusetts Medical School MDBR - A Neurodegeneration with Brain Iron Accumulation Disorder $51,020 2019
Robin Ketteler, PhD. The use of a patient-centric neuronal cell model of Beta-Propeller Protein-Associated Neurodegeneration (BPAN) as a platform to develop novel therapies University College London MDBR - BPAN-A Neurodegeneration with Brain Iron Accumulation Disorder $51,020 2019
Tommaso Pizzorusso, PhD Validation of pupil size as a biomarker for CDKL5 disorder: longitudinal assessment and relationship with disease severity. University of Florence MDBR - CDKL5 $51,382 2019
Nigel Farrow, PhD Airway Cell Therapy for Cystic Fibrosis Nonsense Mutations University of Adelaide MDBR - Cystic Fibrosis $53,668 2019
Amanda Ackermann, MD, PhD Vitamin E Supplementation in Hyperinsulinism/Hyperammonemia Syndrome Children's Hospital of Philadelphia MDBR - Congenital Hyperinsulinism $84,080 2019
May Aung-Htut, PhD Could exon skipping strategies be used as a treatment for recessive Ullrich Congenital Muscular Dystrophy? Murdoch University MDBR - Congenital Muscular Dystrophy $50,699 2019
Suneet Agarwal, MD, PhD Small molecule modulators of telomerase as novel treatments for dyskeratosis congenita Boston Children's Hospital MDBR - Dyskeratosis Congenita $100,373 2019
Andrew Kennedy Tissue-specific and temporal reinstatement of Tcf4 function to treat Pitt-Hopkins Syndrome Bates College MDBR - Pitt Hopkins Syndrome $51,242 2019
1 4 5 6 7 8 27